The Risk of Metabolic Disorders in Patients Treated with Asenapine or Olanzapine- A Real World Data Study Conducted in Italy and Spain
Abstract
Authors
G. Maina C. Ripellino V. Pegoraro C. Caresano
G. Maina C. Ripellino V. Pegoraro C. Caresano
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now